336 related articles for article (PubMed ID: 20156179)
1. Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent "as new use".
Amaral L; Molnar J
Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):109-14. PubMed ID: 20156179
[TBL] [Abstract][Full Text] [Related]
2. Effective therapy with the neuroleptic thioridazine as an adjunct to second line of defence drugs, and the potential that thioridazine offers for new patents that cover a variety of "new uses".
Amaral L; Viveiros M; Molnar J; Kristiansen JE
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):84-7. PubMed ID: 21548876
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which thioridazine in combination with antibiotics cures extensively drug-resistant infections of pulmonary tuberculosis.
Amaral L; Molnar J
In Vivo; 2014; 28(2):267-71. PubMed ID: 24632985
[TBL] [Abstract][Full Text] [Related]
4. Promising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps.
Amaral L; Martins M; Viveiros M; Molnar J; Kristiansen JE
Curr Drug Targets; 2008 Sep; 9(9):816-9. PubMed ID: 18781927
[TBL] [Abstract][Full Text] [Related]
5. Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!
Amaral L; Boeree MJ; Gillespie SH; Udwadia ZF; van Soolingen D
Int J Antimicrob Agents; 2010 Jun; 35(6):524-6. PubMed ID: 20188526
[TBL] [Abstract][Full Text] [Related]
6. The mechanism by which the phenothiazine thioridazine contributes to cure problematic drug-resistant forms of pulmonary tuberculosis: recent patents for "new use".
Amaral L; Martins A; Spengler G; Hunyadi A; Molnar J
Recent Pat Antiinfect Drug Discov; 2013 Dec; 8(3):206-12. PubMed ID: 24320229
[TBL] [Abstract][Full Text] [Related]
7. XDR-TB, what is it; how is it treated; and why is therapeutic failure so high?
Gillespie SH; Singh K
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):77-83. PubMed ID: 21595627
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB.
Udwadia ZF; Sen T; Pinto LM
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):88-91. PubMed ID: 21631417
[TBL] [Abstract][Full Text] [Related]
9. It is anticipated that as is usually the case, financial motivation will move TZ from its current status “potential anti-MDR/XDR agent,” to one that will cure MDR and XDR TB. Foreword.
Amaral L
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):76. PubMed ID: 21796848
[No Abstract] [Full Text] [Related]
10. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
11. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.
Amaral L; Viveiros M
Int J Antimicrob Agents; 2012 May; 39(5):376-80. PubMed ID: 22445204
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
13. Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
Abbate E; Vescovo M; Natiello M; Cufré M; García A; Gonzalez Montaner P; Ambroggi M; Ritacco V; van Soolingen D
J Antimicrob Chemother; 2012 Feb; 67(2):473-7. PubMed ID: 22134348
[TBL] [Abstract][Full Text] [Related]
14. Extensively drug-resistant tuberculosis in california, 1993-2006.
Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
[TBL] [Abstract][Full Text] [Related]
16. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
17. Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TB.
Martins M
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):110-7. PubMed ID: 21517742
[TBL] [Abstract][Full Text] [Related]
18. Global clinical trials for the treatment of TB with thioridazine.
Boeree MJ
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):99-103. PubMed ID: 21548879
[TBL] [Abstract][Full Text] [Related]
19. Thioridazine: an old neuroleptic effective against totally drug resistant tuberculosis.
Amaral L
Acta Med Port; 2012; 25(2):118-21. PubMed ID: 22985923
[TBL] [Abstract][Full Text] [Related]
20. Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.
Amaral L; Molnar J
Expert Rev Anti Infect Ther; 2012 Aug; 10(8):869-73. PubMed ID: 23030326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
